Key result
Cardiac stereotactic body radiation therapy increased effective refractory period (interaction P=0.048) and decreased connexin-43 area density (P<0.01) in a porcine infarct model.
Why the study?
The antiarrhythmic effects and time course of action of cardiac stereotactic body radiation therapy on abnormal ventricular substrate remain poorly understood.
Does 25 Gy single-fraction photon radiation (cSBRT) alter electrophysiological, molecular, and structural properties in a porcine infarct model of ventricular tachycardia?
RCT (n=8)
randomized
Does 25 Gy single-fraction photon radiation (cSBRT) alter electrophysiological, molecular, and structural properties in a porcine infarct model of ventricular tachycardia?
cSBRT produces early electrical remodeling, including increased effective refractory period and decreased connexin-43 density, without increasing fibrosis in a porcine model.
Does not support clinical use of cSBRT for VT; hypothesis-generating for scar substrate modification in infarct models.
BACKGROUND: Cardiac stereotactic body radiation therapy (cSBRT) is a noninvasive, investigational treatment for refractory ventricular tachycardia (VT). The antiarrhythmic effects and time course of action of cSBRT on abnormal ventricular substrate remain poorly understood. OBJECTIVES: This study aimed to investigate the electrophysiological, molecular, and structural changes following cSBRT in a porcine infarct model. METHODS: Anterior myocardial infarction was created in a porcine model of infarct-related re-entrant VT (n = 8). Swine were randomized to cSBRT (n = 4) or control infarct (n = 4) groups. Baseline electrophysiology study and high-resolution electroanatomic maps were performed 8 to 10 weeks postinfarction. The cSBRT group received 25 Gy single-fraction photon radiation guided by initial left ventricular substrate maps. Cardiac magnetic resonance imaging followed by repeat electrophysiology study and mapping studies were performed 6 weeks later. RESULTS: cSBRT resulted in significant prolongation of the effective refractory period in remote, nontargeted myocardium (cSBRT: 216 ± 21-252 ± 11 ms, Δ +17% vs control: 234 ± 7-249 ± 1 ms, Δ +6.5%) and targeted scar tissue (cSBRT: 258 ± 10-291 ± 18 ms, Δ +13% vs control: 274 ± 13-284 ± 8 ms, Δ +3.7%; group × timepoint interaction P = 0.048). Sustained VT was inducible in all 8 subjects at the terminal timepoint. There was a trend toward more prolonged VT cycle length (cSBRT: 195 ± 19-295 ± 55 ms, Δ +53% vs control: 212 ± 15-261 ± 14 ms, Δ +23%; P = 0.22). Connexin-43 immunoreactive area density in the infarct region was lower in the cSBRT group (1.4% vs 2.7%, respectively; P < 0.01). There was no difference detected in late gadolinium enhancement volume (cSBRT: 29.3% ± 7.8% vs control: 27.2% ± 11.3%; P = 0.8) or histologic fibrosis (cSBRT: 54.9% ± 13.4% vs control: 54.6% ± 20.6%; P = 0.95). CONCLUSIONS: Delivery of 25 Gy cSBRT produced early electrical remodeling with increased effective refractory period and decreased connexin-43 area density, without evidence of increased fibrosis.
No takes yet. Share an insight, caveat, or question.
Raissi-Dehkordi et al. (2026) conducted an RCT in Infarct-related re-entrant ventricular tachycardia (n=8). Cardiac stereotactic body radiation therapy (cSBRT) vs. Control infarct was evaluated on Effective refractory period in remote, nontargeted myocardium and targeted scar tissue (p=0.048). Cardiac stereotactic body radiation therapy increased effective refractory period (interaction P=0.048) and decreased connexin-43 area density (P<0.01) in a porcine infarct model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: